Get Premium to unlock powerful stock data

Weekly CEO Buys Highlight

Details the CEO buys this past week for the following companies: Guess?, Intrexon, Odonate Therapeutics, The Chemours and i3 Verticals

Author's Avatar
Joy Hu
Jun 17, 2019
Article's Main Image

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

Guess? CEO bought 347,353 shares

Guess? Inc. (

GES, Financial) CEO and Director Carlos Alberini bought 347,353 shares on June 13 at a price of $14.32. The price of the stock has decreased by 0.63% since.

Guess designs, markets, distributes and licenses contemporary apparel and accessories that reflect European fashion sensibilities under brands including Guess, Marciano and G by Guess. Apparel is sold both through wholesale accounts and retail storefronts with over 1,600 stores and concessions, operated directly and through licensees. The company has a global presence, with about 42% of revenue generated in the Americas. The company has a market cap of $1.02 billion. Its shares traded at $14.23 with a price-earnings ratio of 88.94 as of June 14.

Net loss for the first quarter of fiscal 2020 was $21.4 million compared to $21.2 million for the first quarter of fiscal 2019.

Director Gianluca Bolla bought 10,000 shares on June 12 at a price of $14.73. The price of the stock has decreased by 3.39% since.

Intrexon CEO bought 805,447 shares

Intrexon Corp. (

XON, Financial) CEO and 10% Owner Randal J. Kirk bought 805,447 shares during the past week at the average price of $5.24.

Intrexon is a biotechnology company that develops synthetic biology solutions. The company designs, builds and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company has a market cap of $1.13 billion. Its shares traded at $7.03 as of June 14.

Net loss for the first quarter of 2019 was $62 million compared to $47 million for the prior-year period.

Kirk bought 330,180 shares on May 30 at a price of $4.75; 135,548 shares on June 4 at a price of $4.91; 203,321 shares on June 4 at a price of $4.91; 483,268 shares on June 7 at a price of $5.24; and 322,179 shares on June 7 at a price of $5.24. The price of the stock has increased by 34.16% since.

Odonate Therapeutics CEO bought 76,308 shares

Odonate Therapeutics Inc. (

ODT, Financial) CEO and 10% Owner Kevin C. Tang bought 76,308 shares on June 7 at a price of $27.36. The price of the stock has decreased by 8.63% since.

Odonate Therapeutics is a pharmaceutical company engaged in the development of therapeutics which improves and extend the lives of patients with cancer. It is developing tesetaxel, a chemotherapy agent used in the treatment of cancer. The company has a market cap of $668.67 million. Its shares traded at $25.00 as of June 14.

Net loss for the first quarter of 2019 was $28.65 million compared to $16.88 million for the comparable period of 2018.

Tang also bought 93,692 shares on June 5 at a price of $24.92. The price of the stock has increased by 0.32% since.

The Chemours CEO bought 88,000 shares

The Chemours Co. (

CC, Financial) President and CEO Mark P. Vergnano bought 88,000 shares during the past week at the average price of $23.17.

Chemours is the world's largest and one of the lowest-cost producers of titanium dioxide, a white pigment used in paint. The company also produces fluoroproducts including refrigerants and industrial resins. The company has a market cap of $3.91 billion. Its shares traded at $23.84 with a price-earnings ratio of 5.37 as of June 14.

First quarter net income was $94 million compared to $297 million for the prior-year quarter.

Vergnano bought 44,000 shares on June 10 at a price of $23.17 and another 44,000 shares the same day at a price of $23.17. The price of the stock has increased by 2.89% since.

i3 Verticals CEO bought 84,800 shares

i3 Verticals Inc. (IIIV) CEO and 10% Owner Gregory S. Daily bought 84,800 shares on June 11 at a price of $23.49. The price of the stock has increased by 5.45% since.

i3 Verticals provides technology-driven methods for its clients to process payments spanning across point-of-sale, e-commerce and mobile payment transactions. Its clients operate in markets such as education, non-profit, public sector, property management and health care. The company has a market cap of $676.54 million. Its shares traded at $24.77 with a price-earnings ratio of 78.39 as of June 14.

Net loss for the second quarter of fiscal 2019 was $1.22 million compared to net loss of $6.84 million for the prior year quarter.

For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned.

Read more here: 

52-Week Company Lows 

Weekly CEO Buys Highlight 

52-Week Company Lows 

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
Rating:
0 / 5 (0 votes)

Please Login to leave a comment

Author's Avatar

Joy Hu